Fuereder, Thorsten http://orcid.org/0000-0001-5356-6452
Funding for this research was provided by:
Medical University of Vienna
Article History
Received: 31 July 2022
Accepted: 21 September 2022
First Online: 29 October 2022
Conflict of interest
: T. Fuereder is member of advisory boards and/or received honoraria from MSD, MERCK, Roche, Novartis, Amgen, Pfizer, BMS and Boehringer Ingelheim, Takeda and Janssen. Research funding was received from MSD and MERCK.